November 13, 2026
$RichWire Markets and money, explained simply
LIVE
Freelancer Details Platform Scale and Revenue Breakdown at Investor Event Pelthos Therapeutics Reports 114% Surge in Third-Quarter Revenue Fincantieri Posts Q3 EBITDA Jump Despite Flat Revenue Prediction Markets Point to Potential Successors as Nvidia Faces Leadership Transition M-tron Industries Hosts Third-Quarter 2026 Earnings Call Belite Bio Outlines Progress During Third Quarter 2026 Earnings Call BioCardia Details Financial Results and Corporate Strategy in Third-Quarter 2026 Update INVE Technologies Holds Q3 2026 Earnings Call Under New Identity Olema Pharmaceuticals Updates Investors on Clinical Trials at Healthcare Conference Wolverine Worldwide Delivers Strong Q3 Growth Driven by Active Footwear Brands Curis Outlines Q3 2026 Progress in Lead Lymphoma Clinical Program Procter & Gamble Versus Starbucks: Evaluating 2027 Investment Prospects Freelancer Details Platform Scale and Revenue Breakdown at Investor Event Pelthos Therapeutics Reports 114% Surge in Third-Quarter Revenue Fincantieri Posts Q3 EBITDA Jump Despite Flat Revenue Prediction Markets Point to Potential Successors as Nvidia Faces Leadership Transition M-tron Industries Hosts Third-Quarter 2026 Earnings Call Belite Bio Outlines Progress During Third Quarter 2026 Earnings Call BioCardia Details Financial Results and Corporate Strategy in Third-Quarter 2026 Update INVE Technologies Holds Q3 2026 Earnings Call Under New Identity Olema Pharmaceuticals Updates Investors on Clinical Trials at Healthcare Conference Wolverine Worldwide Delivers Strong Q3 Growth Driven by Active Footwear Brands Curis Outlines Q3 2026 Progress in Lead Lymphoma Clinical Program Procter & Gamble Versus Starbucks: Evaluating 2027 Investment Prospects

Topic: BDJ

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.